Trial Profile
Prospective modeling study comparing clinical efficacy of timely use of TNF inhibitors against delayed use in treatment of Psoriatic arthritis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2016
Price :
$35
*
At a glance
- Drugs Apremilast (Primary) ; Adalimumab; Etanercept; Golimumab; Infliximab
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- 11 Feb 2016 New trial record